ORASURE TECHNOLOGIES INC Logo

ORASURE TECHNOLOGIES INC

Develops and distributes point-of-care diagnostic tests and sample collection devices.

OSUR | NDAQ

Overview

Corporate Details

ISIN(s):
US68554V1089
LEI:
Country:
United States of America
Address:
220 E FIRST ST, 18015 BETHLEHEM
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OraSure Technologies, Inc. is a leader in the development, manufacture, and distribution of point-of-care diagnostic tests and sample collection devices. Together with its subsidiaries, including DNA Genotek and Sherlock Biosciences, the company provides innovative solutions for discovering and detecting critical medical conditions. Its product portfolio features rapid diagnostic tests for infectious diseases such as HIV and HCV, as well as sample collection and stabilization technologies. OraSure focuses on improving healthcare access and quality through effortless, often oral fluid-based, testing solutions. The company's products are sold globally to a diverse market, including clinical laboratories, hospitals, public health organizations, government agencies, pharmaceutical companies, and direct to consumers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ORASURE TECHNOLOGIES INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ORASURE TECHNOLOGIES INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ORASURE TECHNOLOGIES INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Atara Biotherapeutics, Inc. Logo
Pioneering off-the-shelf allogeneic T-cell immunotherapies for cancer and autoimmune diseases.
United States of America ATRA
Atea Pharmaceuticals, Inc. Logo
A clinical-stage biopharma developing oral antiviral therapies for viruses like Hepatitis C.
United States of America AVIR
Athira Pharma, Inc. Logo
Developing small-molecule therapies to slow neurodegeneration in diseases like Alzheimer's.
United States of America ATHA
ATOSSA THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing (Z)-endoxifen for breast cancer treatment and prevention.
United States of America ATOS
Bioengineering solutions to accelerate life sciences research, from gene synthesis to cell lines.
South Korea 355690
aTYR PHARMA INC Logo
Developing novel medicines for fibrosis and inflammation using tRNA synthetase biology.
United States of America ATYR
Aura Biosciences, Inc. Logo
Developing virus-like therapies to selectively destroy solid tumors in ocular & urologic oncology.
United States of America AURA
Aurinia Pharmaceuticals Inc. Logo
Biopharma developing therapies for autoimmune and kidney diseases like lupus nephritis.
United States of America AUPH
AURORA CANNABIS INC Logo
A global producer and seller of medical and recreational cannabis and derivative products.
United States of America ACB
Autolus Therapeutics plc Logo
Develops programmed CAR T-cell therapies for cancer and autoimmune diseases.
United States of America AUTL

Talk to a Data Expert

Have a question? We'll get back to you promptly.